These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26503843)

  • 1. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
    Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
    Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DASH diet on lipid profiles and biomarkers of oxidative stress in overweight and obese women with polycystic ovary syndrome: a randomized clinical trial.
    Asemi Z; Samimi M; Tabassi Z; Shakeri H; Sabihi SS; Esmaillzadeh A
    Nutrition; 2014; 30(11-12):1287-93. PubMed ID: 25194966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
    Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
    Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DASH diet, insulin resistance, and serum hs-CRP in polycystic ovary syndrome: a randomized controlled clinical trial.
    Asemi Z; Esmaillzadeh A
    Horm Metab Res; 2015 Mar; 47(3):232-8. PubMed ID: 24956415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes.
    Asemi Z; Samimi M; Tabassi Z; Sabihi SS; Esmaillzadeh A
    Nutrition; 2013 Apr; 29(4):619-24. PubMed ID: 23466048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M; Karimi-Zarchi M; Salehi-Abargouei A; Fallahzadeh H; Nadjarzadeh A
    J Hum Nutr Diet; 2017 Jun; 30(3):275-283. PubMed ID: 28466507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dietary approaches to stop hypertension diet on weight loss, anti-Müllerian hormone and metabolic profiles in women with polycystic ovary syndrome: A randomized clinical trial.
    Foroozanfard F; Rafiei H; Samimi M; Gilasi HR; Gorjizadeh R; Heidar Z; Asemi Z
    Clin Endocrinol (Oxf); 2017 Jul; 87(1):51-58. PubMed ID: 28316072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
    Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
    Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a high monounsaturated vs high polyunsaturated fat hypocaloric diets in nonalcoholic fatty liver disease.
    Aller R; de Luis DA; Izaola O; de la Fuente B; Bachiller R
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1041-7. PubMed ID: 24763885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the dietary approaches to stop hypertension diet alone and in combination with exercise and caloric restriction on insulin sensitivity and lipids.
    Blumenthal JA; Babyak MA; Sherwood A; Craighead L; Lin PH; Johnson J; Watkins LL; Wang JT; Kuhn C; Feinglos M; Hinderliter A
    Hypertension; 2010 May; 55(5):1199-205. PubMed ID: 20212264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is associated with lower presence of non-alcoholic fatty liver disease in middle-aged and elderly adults.
    Xiao ML; Lin JS; Li YH; Liu M; Deng YY; Wang CY; Chen YM
    Public Health Nutr; 2020 Mar; 23(4):674-682. PubMed ID: 31566148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calorie-Restricted Mediterranean and Low-Fat Diets Affect Fatty Acid Status in Individuals with Nonalcoholic Fatty Liver Disease.
    Ristic-Medic D; Kovacic M; Takic M; Arsic A; Petrovic S; Paunovic M; Jovicic M; Vucic V
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33374554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Alami F; Alizadeh M; Shateri K
    Scand J Gastroenterol; 2022 Oct; 57(10):1238-1249. PubMed ID: 35710164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a novel therapeutic diet on liver enzymes and coagulating factors in patients with non-alcoholic fatty liver disease: A parallel randomized trial.
    Kani AH; Alavian SM; Esmaillzadeh A; Adibi P; Azadbakht L
    Nutrition; 2014; 30(7-8):814-21. PubMed ID: 24984998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study.
    Watanabe M; Risi R; Camajani E; Contini S; Persichetti A; Tuccinardi D; Ernesti I; Mariani S; Lubrano C; Genco A; Spera G; Gnessi L; Basciani S
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
    Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
    Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the glycemic index of the diet on weight loss, modulation of satiety, inflammation, and other metabolic risk factors: a randomized controlled trial.
    Juanola-Falgarona M; Salas-Salvadó J; Ibarrola-Jurado N; Rabassa-Soler A; Díaz-López A; Guasch-Ferré M; Hernández-Alonso P; Balanza R; Bulló M
    Am J Clin Nutr; 2014 Jul; 100(1):27-35. PubMed ID: 24787494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleoylethanolamide supplementation in obese patients newly diagnosed with non-alcoholic fatty liver disease: Effects on metabolic parameters, anthropometric indices, and expression of PPAR-α, UCP1, and UCP2 genes.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Hosseinzadeh-Attar MJ; Shakeri A; Asghari-Jafarabadi M; Roshanravan N; Farrin N; Naemi M; Hasankhani M
    Pharmacol Res; 2020 Jun; 156():104770. PubMed ID: 32217148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
    Panahi Y; Ghamarchehreh ME; Beiraghdar F; Zare R; Jalalian HR; Sahebkar A
    Hepatogastroenterology; 2012 Oct; 59(119):2099-2103. PubMed ID: 23234816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar Weight Loss Induces Greater Improvements in Insulin Sensitivity and Liver Function among Individuals with NAFLD Compared to Individuals without NAFLD.
    Schübel R; Nonnenmacher T; Sookthai D; Gonzalez Maldonado S; Sowah SA; von Stackelberg O; Schlett CL; Grafetstätter M; Nabers D; Johnson T; Kirsten R; Ulrich CM; Kaaks R; Kauczor HU; Kühn T; Nattenmüller J
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30836637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.